تحميل
NASDAQHealthcareMedical - Devices
أحدث البيانات المتاحة
6.37 US$
−0.08 US$ · -1.24%
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
الإغلاق السابق
6.37 US$
−0.08 US$ · -1.24%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
نطاق اليوم
السعر الحالي 6.37 US$
نطاق 52 أسبوعًا
السعر الحالي 6.37 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
76
أقل من القيمة
المشاعر
60
مختلط
المخاطر
70
مخاطر مرتفعة
الزخم
28
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
نطاق اليوم
السعر الحالي 6.37 US$
نطاق 52 أسبوعًا
السعر الحالي 6.37 US$
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
عينة محدودة من 3 تقييمات
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI2.32 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Extended Market ETFVXF960.58 ألف0.00%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Small Cap ETFDFAS251.69 ألف0.00%33.87 مليار USD0.31%78.35 US$+0.32%
iShares Micro-Cap ETFIWC198.68 ألف0.02%1.32 مليار USD0.60%183 US$+0.11%
Dimensional - US Targeted Value ETFDFAT142.47 ألف0.00%30.12 مليار USD0.33%67.27 US$-0.43%
U.S. Micro Cap Portfolio ETFDFMC87.86 ألف0.00%7.56 مليار USD0.43%57.813 US$+0.20%
Avantis U.S. Small Cap Equity ETFAVSC6.51 ألف—3.08 مليار USD0.25%69.98 US$+0.03%
Dimensional - US Core Equity 2 ETFDFAC4.4 ألف0.00%88.6 مليار USD0.21%45.33 US$+0.49%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Micro-Cap ETFIWCDimensional - US Targeted Value ETFDFATU.S. Micro Cap Portfolio ETFDFMCAvantis U.S. Small Cap Equity ETFAVSCDimensional - US Core Equity 2 ETFDFACالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
